4.2 Article

World Health Organization risk drinking levels as a treatment outcome measure in topiramate trials

Related references

Note: Only part of the references are listed.
Article Substance Abuse

Stability of Posttreatment Reductions in World Health Organization (WHO) Drinking Risk Levels and Posttreatment Functioning in Older Adults with DSM-5 Alcohol Use Disorder: Secondary Data Analysis of the Elderly Study

Anna Mejldal et al.

Summary: The study showed that reductions in WHO risk levels were maintained over time in older adults seeking treatment for AUD, and were associated with decreased consequences of drinking and AUD symptoms, as well as minor but statistically significant improvements in quality of life.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2021)

Article Substance Abuse

Combined analysis of the moderating effect of a GRIK1 polymorphism on the effects of topiramate for treating alcohol use disorder

Henry R. Kranzler et al.

Summary: Combining the findings of two studies, it was found that topiramate has a significant effect on reducing heavy drinking and alcohol-related problems, but the rs2832407 genotype does not moderate its therapeutic effects.

DRUG AND ALCOHOL DEPENDENCE (2021)

Article Substance Abuse

Reduction in World Health Organization Risk Drinking Levels and Cardiovascular Disease

Justin Knox et al.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2020)

Article Substance Abuse

Reduced Drinking in Alcohol Dependence Treatment, What Is the Evidence?

Karl Mann et al.

EUROPEAN ADDICTION RESEARCH (2017)

Review Substance Abuse

Ethanol Metabolites: Their Role in the Assessment of Alcohol Intake

Friedrich M. Wurst et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2015)

Review Substance Abuse

A Meta-Analysis of Topiramate's Effects for Individuals with Alcohol Use Disorders

Janet C. Blodgett et al.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH (2014)

Article Substance Abuse

Burden of Disease Associated with Alcohol Use Disorders in the United States

Juergen Rehm et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2014)

Article Psychiatry

Topiramate Treatment for Heavy Drinkers: Moderation by a GRIK1 Polymorphism

Henry R. Kranzler et al.

AMERICAN JOURNAL OF PSYCHIATRY (2014)

Article Substance Abuse

Posttreatment Low-Risk Drinking as a Predictor of Future Drinking and Problem Outcomes Among Individuals with Alcohol Use Disorders

Andrea H. Kline-Simon et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2013)

Article Public, Environmental & Occupational Health

Stigma and Treatment for Alcohol Disorders in the United States

K. M. Keyes et al.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2010)

Article Substance Abuse

Association of Markers in the 3' Region of the GluR5 Kainate Receptor Subunit Gene to Alcohol Dependence

Henry R. Kranzler et al.

ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH (2009)

Article Substance Abuse

Comparing topiramate with naltrexone in the treatment of alcohol dependence

Danilo Antonio Baltieri et al.

ADDICTION (2008)

Article Medicine, General & Internal

Topiramate for treating alcohol dependence - A randomized controlled trial

Bankole A. Johnson et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)

Article Medicine, General & Internal

Oral topiramate for treatment of alcohol dependence: a randomised controlled trial

BA Johnson et al.

LANCET (2003)